INDEVUS PHARMACEUTICALS INC·4

Dec 8, 5:10 PM ET

INDEVUS PHARMACEUTICALS INC 4

4 · INDEVUS PHARMACEUTICALS INC · Filed Dec 8, 2008

Insider Transaction Report

Form 4
Period: 2008-12-04
BUTLER MARK S
Executive Vice President
Transactions
  • Award

    Stock Option (Right to Buy)

    2008-12-04+60,00060,000 total
    Exercise: $5.00Exp: 2010-06-10Common Stock, $.001 par value per share (60,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2008-12-0460,0000 total
    Exercise: $5.00Exp: 2009-06-10Common Stock, $.001 par value per share (60,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2008-12-04550,0000 total
    Exercise: $6.19Exp: 2009-06-10Common Stock, $.001 par value per share (550,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2008-12-04+550,000550,000 total
    Exercise: $6.19Exp: 2010-06-10Common Stock, $.001 par value per share (550,000 underlying)
Footnotes (3)
  • [F1]All of the reported transactions involved the amendment of outstanding stock options to extend the respective expiration dates from 6/10/2009 to 6/10/2010; such extensions are considered by the Securities and Exchange Commission to be cancellations of the current stock options.
  • [F2]Prior to the extension of the current stock option, such stock option was fully exercisable.
  • [F3]This stock option is fully exercisable as of the date of this report.

Documents

1 file
  • 4
    rrd225748.xmlPrimary